TABLE 4.
Common TEAEs in the Safety Population (≥ 10% in either group or rate difference of ≥ 5% between ixazomib and placebo groups) Plus Other TEAEs of Clinical Interest
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.